18β-Glycyrrhetinic acid exerts protective effects against cyclophosphamide-induced hepatotoxicity: potential role of PPARγ and Nrf2 upregulation

Genes and Nutrition

Volumn 10, Issue 6, 2015, Pages

  Mahmoud, Ayman M ^a   Al Dera, Hussein S ^b  

^a BENI SUEF UNIVERSITY   (Egypt)

^b KING SAUD BIN ABDULAZIZ UNIVERSITY FOR HEALTH SCIENCES   (Saudi Arabia)

Author keywords

Chemotherapy; Hepatotoxicity; Inflammation; Nrf2; PPARs

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; CATALASE; CYCLOPHOSPHAMIDE; GAMMA GLUTAMYLTRANSFERASE; GLUTATHIONE; GLUTATHIONE PEROXIDASE; GLYCYRRHETINIC ACID; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 1BETA; INTERLEUKIN 6; LACTATE DEHYDROGENASE; NITRIC OXIDE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; SUPEROXIDE DISMUTASE; TRANSCRIPTION FACTOR NRF2; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG MECHANISM; ENZYME ACTIVATION; GENE EXPRESSION; HISTOPATHOLOGY; IMMUNOSUPPRESSIVE TREATMENT; LABORATORY TEST; LIPID PEROXIDATION; LIVER PROTECTION; LIVER TOXICITY; MALE; NONHUMAN; OXIDATIVE STRESS; PROTEIN EXPRESSION; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UPREGULATION; WESTERN BLOTTING;

EID: 84942306612     PISSN: 15558932     EISSN: 18653499     Source Type: Journal    
DOI: 10.1007/s12263-015-0491-1     Document Type: Article

References (82)

1. Ahmadi A, Hosseinimehr S, Naghshvar F, Hajir E, Ghahremani M (2008) Chemoprotective effects of hesperidin against genotoxicity induced by cyclophosphamide in mice bone marrow cells. Arch Pharm Res 31:794–797
2. Akay H, Akay T, Secilmis S, Kocak Z, Donderici O (2006) Hepatotoxicity after low-dose cyclophosphamide therapy. South Med J 99:1399–1400
3. Akcay A, Nguyen Q, Edelstein CL (2009) Mediators of inflammation in acute kidney injury. Mediators Inflamm 2009:137072
4. Al-Yahya AA, Al-Majed AA, Gado AM, Daba MH, Al-Shabanah OA, Abd-Allah AR (2009) Acacia senegal gum exudate offers protection against cyclophosphamide-induced urinary bladder cytotoxicity. Oxid Med Cell Longev 2:207–213
5. Bardag-Gorce F, Oliva J, Lin A, Li J, French BA, French SW (2011) Proteasome inhibitor up regulates liver antioxidative enzymes in rat model of alcoholic liver disease. Exp Mol Pathol 90:123–130
6. Barish GD, Narkar VA, Evans RM (2006) PPARδ: a dagger in the heart of the metabolic syndrome. J Clin Investig 116:590–597
7. Berger J, Moller DE (2002) The mechanisms of action of PPARs. Annu Rev Med 53:409–435
8. Beutler E, Duron O, Kelly BM (1963) Improved method for the determination of blood glutathione. J Lab Clin Med 61:882–888
9. Bhatia K, Ahmad F, Rashid H, Raisuddin S (2008) Protective effect of S-allylcysteine against cyclophosphamide-induced bladder hemorrhagic cystitis in mice. Food Chem Toxicol 46:3368–3374
10. Bowie A, O’Neill LA (2000) Oxidative stress and nuclear factor-kappa B activation: a reassessment of the evidence in the light of recent discoveries. Biochem Pharmacol 59:13–23
11. Chen S, Zou L, Li L, Wu T, Uversky VN (2013) The protective effect of glycyrrhetinic acid on carbon tetrachloride-induced chronic liver fibrosis in mice via upregulation of Nrf2. PLoS ONE 8:e53662
12. Cho HY, Gladwell W, Wang X et al (2010) Nrf2-regulated PPARγ expression is critical to protection against acute lung injury in mice. Am J Respir Crit Care Med 182:170–182
13. Circu ML, Aw TY (2011) Redox biology of the intestine. Free Radic Res 45:1245–1266
14. Cohen G, Dembiec D, Marcus J (1970) Measurement of catalase activity in tissue extracts. Anal Biochem 34:30–38
15. Copple IM, Goldring CE, Kitteringham NR, Park BK (2010) The Keap1-Nrf2 cellular defense pathway: mechanisms of regulation and role in protection against drug-induced toxicity. Handb Exp Pharmacol 196:233–266
16. Dang K, Lamb K, Cohen M, Bielefeldt K, Gebhart GF (2008) Cyclophosphamide-induced bladder inflammation sensitizes and enhances P2X receptor function in rat bladder sensory neurons. J Neurophysiol 99:49–59
17. De Bosscher K, Vanden Berghe W, Haegeman G (2006) Cross-talk between nuclear receptors and nuclear factor kappa B. Oncogene 25:6868–6886
18. de Jonge ME, Huitema AD, Beijnen JH, Rodenhuis S (2006) High exposures to bioactivated cyclophosphamide are related to the occurrence of veno-occlusive disease of the liver following high-dose chemotherapy. Br J Cancer 94:1226–1230
19. Dobrian AD, Schriver SD, Khraibi AA, Prewitt RL (2004) Pioglitazone prevents hypertension and reduces oxidative stress in diet-induced obesity. Hypertension 43:48–56
20. Eisenbrand G (2006) Glycyrrhizin. Mol Nutr Food Res 50:1087–1088
21. Farombi EO, Shrotriya S, Na H-K, Kim S-H, Surh Y-J (2008) Curcumin attenuates dimethylnitrosamine-induced liver injury in rats through Nrf2-mediated induction of heme oxygenase-1. Food Chem Toxicol 46:1279–1287
22. Fraiser LH, Kanekal S, Kehrer JP (1991) Cyclophosphamide toxicity: characterising and avoiding the problem. Drugs 42:781–795
23. Franco R, Schoneveld OJ, Pappa A, Panayiotidis MI (2007) The central role of glutathione in the pathophysiology of human diseases. Arch Physiol Biochem 113:234–258
24. Garg R, Kumbkarni Y, Aljada A et al (2000) Troglitazone reduces reactive oxygen species generation by leukocytes and lipid peroxidation and improves flow-mediated vasodilatation in obese subjects. Hypertension 36:430–435
25. Germoush MO, Mahmoud AM (2014) Berberine mitigates cyclophosphamide-induced hepatotoxicity by modulating antioxidant status and inflammatory cytokines. J Cancer Res Clin Oncol 140:1103–1109
26. Girnun GD, Domann FE, Moore SA, Robbins ME (2002) Identification of a functional peroxisome proliferator-activated receptor response element in the rat catalase promoter. Mol Endocrinol 16:2793–2801
27. Gong P, Xu H, Zhang J, Wang Z (2012) PPAR expression and its association with SOD and NF-κB in rats with obstructive jaundice. Biomed Res India 23:551–560
28. Hasan S, Khan R, Ali N et al (2015) 18-β glycyrrhetinic acid alleviates 2-acetylaminofluorene-induced hepatotoxicity in Wistar rats: role in hyperproliferation, inflammation and oxidative stress. Hum Exp Toxicol 34:628–641
29. Hong Y, Yan W, Chen S, Cr Sun, Zhang JM (2010) The role of Nrf2 signaling in the regulation of antioxidants and detoxifying enzymes after traumatic brain injury in rats and mice. Acta Pharmacol Sin 31(11):1421–1430
30. Ishida Y, Kondo T, Ohshima T, Fujiwara H, Iwakura Y, Mukaida N (2002) A pivotal involvement of IFN-γ in the pathogenesis of acetaminophen-induced acute liver injury. FASEB J 16:1227–1236
31. Kang MI, Kobayashi A, Wakabayashi N, Kim SG, Yamamoto M (2004) Scaffolding of Keap1 to the actin cytoskeleton controls the function of Nrf2 as key regulator of cytoprotective phase 2 genes. Proc Natl Acad Sci USA 101:2046–2051
32. Kensler TW, Wakabayashi N, Biswal S (2007) Cell survival responses to environmental stresses via the Keap1-Nrf2-ARE pathway. Annu Rev Pharmacol 47:89–116
33. Kern JC, Kehrer JP (2002) Acrolein-induced cell death: a caspase-influenced decision between apoptosis and oncosis/necrosis. Chem Biol Interact 139:79–95
34. Klaassen CD, Casarett LJ, Doull J (2008) Casarett and Doull’s toxicology: the basic science of poisons, 7th edn. McGraw-Hill, New York
35. Kobayashi M, Yamamoto M (2005) Molecular mechanisms activating the Nrf2-Keap1 pathway of antioxidant gene regulation. Antioxid Redox Signal 7:385–394
36. Kwak MK, Itoh K, Yamamoto M, Sutter TR, Kensler TW (2001) Role of transcription factor Nrf2 in the induction of hepatic phase 2 and antioxidative enzymes in vivo by the cancer chemoprotective agent, 3H-1, 2-dimethiole-3-thione. Mol Med 7:135–145
37. Lameire N, Kruse V, Rottey S (2011) Nephrotoxicity of anticancer drugs—an underestimated problem? Acta Clin Belg 66:337–345
38. Lee JM, Li J, Johnson DA, Stein TD, Kraft AD, Calkins MJ, Jakel RJ, Johnson JA (2005) Nrf2, a multi-organ protector? FASEB J 19:1061–1066
39. Livak KJ, Schmittgen TD (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25:402–408
40. Mahmoud AM (2014) Hesperidin protects against cyclophosphamide-induced hepatotoxicity by upregulation of PPARγ and abrogation of oxidative stress and inflammation. Can J Physiol Pharmacol 92:717–724
41. Mahmoud AM, Hussein OE, Ramadan SA (2013) Amelioration of cyclophosphamide-induced hepatotoxicity by the brown seaweed Turbinaria ornata. Int J Clin Toxicol 1:9–17
42. Mahmoud AM, Germoush MO, Soliman AS (2014) Berberine attenuates isoniazid-induced hepatotoxicity by modulating peroxisome proliferator-activated receptor gamma, oxidative stress and inflammation. Int J Pharmacol 10:451–460
43. Maitraie D, Hung CF, Tu HY et al (2009) Synthesis, anti-inflammatory, and antioxidant activities of 18β-glycyrrhetinic acid derivatives as chemical mediators and xanthine oxidase inhibitors. Bioorg Med Chem 17:2785–2792
44. Marfella R, D’Amico M, Esposito K et al (2006) The ubiquitin-proteasome system and inflammatory activity in diabetic atherosclerotic plaques: effects of rosiglitazone treatment. Diabetes 55:622–632
45. Marklund S, Marklund G (1974) Involvement of the superoxide anion radical in the autoxidation of pyrogallol and a convenient assay for superoxide dismutase. Eur J Biochem 47:469–474
46. Martínez-Gabarrón M, Enríquez R, Sirvent AE, García-Sepulcre M, Millán I, Amorós F (2011) Hepatotoxicity following cyclophosphamide treatment in a patient with MPO-ANCA vasculitis. Nefrologia 31:496–498
47. Matata BM, Galiñanes M (2002) Peroxynitrite is an essential component of cytokines production mechanism in human monocytes through modulation of nuclear factor-kappa B DNA binding activity. J Biol Chem 277:2330–2335
48. Mathers J, Fraser JA, McMahon M, Saunders RD, Hayes JD, McLellan LI (2004) Antioxidant and cytoprotective responses to redox stress. Biochem Soc Symp 71:157–176
49. Matkovics B, Szabo L, Varga IS (1998) Determination of enzyme activities in lipid peroxidation and glutathione pathways (in Hungarian). Lab Diagn 15:248–249
50. McKim SE, Gäbele E, Isayama F et al (2003) Inducible nitric oxide synthase is required in alcohol-induced liver injury: studies with knockout mice. Gastroenterology 125:1834–1844
51. Michalik L, Wahli W (2008) PPARs mediate lipid signaling in inflammation and cancer. PPAR Res 2008:1–15
52. Mohammed NA, Abd El-Aleem SA, El-Hafiz HA, McMahon RF (2004) Distribution of constitutive (COX-1) and inducible (COX-2) cyclooxygenase in postviral human liver cirrhosis: a possible role for COX-2 in the pathogenesis of liver cirrhosis. J Clin Pathol 57:350–354
53. Montgomery HAC, Dymock JF (1961) The determination of nitrite in water. Analyst 86:414–416
54. Montoro P, Maldini M, Russo M, Postorino S, Piacente S, Pizza C (2011) Metabolic profiling of roots of liquorice (Glycyrrhiza glabra) from different geographical areas by ESI/MS/MS and determination of major metabolites by LC-ESI/MS and LC-ESI/MS/MS. J Pharm Biomed Anal 54:535–544
55. Motawi TMK, Sadik NAH, Refaat A (2010) Cytoprotective effects of DL-alpha-lipoic acid or squalene on cyclophosphamide-induced oxidative injury: an experimental study on rat myocardium, testicles and urinary bladder. Food Chem Toxicol 48:2326–2336
56. Nan YM, Fu N, Wu WJ et al (2009) Rosiglitazone prevents nutritional fibrosis and steatohepatitis in mice. Scand J Gastroenterol 44:358–365
57. Okuno Y, Matsuda M, Kobayashi H et al (2008) Adipose expression of catalase is regulated via a novel remote PPARγ-responsive region. Biochem Biophys Res Commun 366:698–704
58. Papaldo P, Lopez M, Marolla P et al (2005) Impact of five prophylactic filgrastim schedules on hematologic toxicity in early breast cancer patients treated with epirubicin and cyclophosphamide. J Clin Oncol 23:6908–6918
59. Pascual G, Fong AL, Ogawa S et al (2005) A SUMOylation-dependent pathway mediates transrepression of inflammatory response genes by PPAR-γ. Nature 437:759–763
60. Patel R, Maru G (2008) Polymeric black tea polyphenols induce phase II enzymes via Nrf2 in mouse liver and lungs. Free Radic Biol Med 44:1897–1911
61. Persijn JP, van der Slik W (1976) A new method for the determination of γ-glutamyltransferase in serum. Z Klin Chem Klin Biochem 14:421–427
62. Peyrou M, Ramadori P, Bourgoin L, Foti M (2012) PPARs in liver diseases and cancer: epigenetic regulation by microRNAs. PPAR Res 2012:757803
63. Pezzuto JM (1997) Plant-derived anticancer agents. Biochem Pharmacol 53:121–133
64. Pikarsky E, Porat RM, Stein I et al (2004) NF-κB functions as a tumour promoter in inflammation-associated cancer. Nature 431:461–466
65. Preuss HG, Jarrell ST, Scheckenbach R, Lieberman S, Anderson RA (1998) Comparative effects of chromium, vanadium and gymnema sylvestre on sugar-induced blood pressure elevations in SHR. J Am Coll Nutr 17:116–123
66. Ramaiah SK (2007) A toxicologist guide to the diagnostic interpretation of hepatic biochemical parameters. Food Chem Toxicol 45:1551–1557
67. Schumann G, Klauke R (2003) New IFCC reference procedures for the determination of catalytic activity concentrations of five enzymes in serum: preliminary upper reference limits obtained in hospitalized subjects. Clin Chim Acta 327:69–79
68. Shanafelt TD, Lin T, Geyer SM et al (2007) Pentostatin, cyclophosphamide, and rituximab regimen in older patients with chronic lymphocytic leukemia. CNCR Cancer 109:2291–2298
69. Shih AY, Imbeault S, Barakauskas V et al (2005) Induction of the Nrf2-driven antioxidant response confers neuroprotection during mitochondrial stress in vivo. J Biol Chem 280:22925–22936
70. Shin SM, Yang JH, Ki SH (2013) Role of the Nrf2-ARE pathway in liver diseases. Oxid Med Cell Longev 2013:763257
71. Srivastava A, Shivanandappa T (2010) Hepatoprotective effect of the root extract of Decalepis hamiltonii against carbon tetrachloride-induced oxidative stress in rats. Food Chem 118:411–417
72. Tacke F, Luedde T, Trautwein C (2009) Inflammatory pathways in liver homeostasis and liver injury. Clin Rev Allergy Immunol 36:4–12
73. Teitz N (1986) Fundamentals of clinical chemistry. W. B. Saunders Co., Philadelphia
74. Tripathi DN, Jena GB (2009) Intervention of astaxanthin against cyclophosphamide-induced oxidative stress and DNA damage: a study in mice. Chem Biol Interact 180:398–406
75. Uber WE, Self SE, Van Bakel AB, Pereira NL (2007) Acute antibody-mediated rejection following heart transplantation. Am J Transplant 7:2064–2074
76. Wang YP, Cheng ML, Zhang BF, Mu M, Wu J (2010) Effects of blueberry on hepatic fibrosis and transcription factor Nrf2 in rats. World J Gastroenterol 16:2657–2663
77. Wang CY, Kao TC, Lo WH, Yen GC (2011) Glycyrrhizic acid and 18β-glycyrrhetinic acid modulate lipopolysaccharide-induced inflammatory response by suppression of NF-κB through PI3 K p110δ and p110γ inhibitions. J Agric Food Chem 59:7726–7733
78. Webster D (1974) A study of the interaction of bromocresol green with isolated serum globulin fractions. Clin Chim Acta 53:109–115
79. Wei XJ, Hu TJ, Chen JR, Wei YY (2011) Inhibitory effect of carboxymethylpachymaran on cyclophosphamide-induced oxidative stress in mice. Int J Biol Macromol 49:801–805
80. Wenger C, Kaplan A, Rubaltelli FF, Hammerman C (1984) Alkaline phosphatase. Clin Chem. The C.V. Mosby Co. St Louis, Toronto. Princeton. 1094–1098
81. Yousefipour Z, Ranganna K, Newaz MA, Milton SG (2005) Mechanism of acrolein-induced vascular toxicity. J Physiol Pharmacol 56:337–353
82. Zhang F, Lu Y, Zheng S (2012) Peroxisome proliferator-activated receptor-γ cross-regulation of signaling events implicated in liver fibrogenesis. Cell Signal 24(3):596–605